GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (FRA:2Q5) » Definitions » Ending Cash Position

Renovaro (FRA:2Q5) Ending Cash Position : €0.29 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Renovaro Ending Cash Position?

Renovaro's Ending Cash Position for the quarter that ended in Mar. 2024 was €0.29 Mil.

Renovaro's quarterly Ending Cash Position declined from Sep. 2023 (€0.49 Mil) to Dec. 2023 (€0.22 Mil) but then increased from Dec. 2023 (€0.22 Mil) to Mar. 2024 (€0.29 Mil).

Renovaro's annual Ending Cash Position declined from Jun. 2021 (€17.15 Mil) to Jun. 2022 (€8.68 Mil) and declined from Jun. 2022 (€8.68 Mil) to Jun. 2023 (€1.73 Mil).


Renovaro Ending Cash Position Historical Data

The historical data trend for Renovaro's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renovaro Ending Cash Position Chart

Renovaro Annual Data
Trend Mar13 Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.87 7.72 17.15 8.68 1.73

Renovaro Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.75 1.73 0.49 0.22 0.29

Renovaro Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Renovaro's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=8.466+-6.736
=1.73

Renovaro's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.225+0.063
=0.29


Renovaro Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Renovaro's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Renovaro (FRA:2Q5) Business Description

Traded in Other Exchanges
Address
2080 Century Park East, Suite 906, Los Angeles, CA, USA, 90067
Renovaro Biosciences Inc Formerly Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.

Renovaro (FRA:2Q5) Headlines

No Headlines